Bristol-Myers Squibb buy tamam
Start price
03.01.19
/
50%
€43.41
Target price
04.11.21
€72.00
Performance (%)
17.75%
End price
05.11.21
€51.12
Summary
This prediction ended on 05.11.21 with a price of €51.12. The prediction had a final performance of 17.75%. A total of €4.86 was paid as dividends for this prediction. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | -3.271% | -3.271% | 11.812% | -22.150% |
| iShares Core DAX® | 2.554% | 0.562% | 14.142% | 49.144% |
| iShares Nasdaq 100 | 2.742% | -0.599% | 30.370% | 82.047% |
| iShares Nikkei 225® | 6.584% | 4.336% | 49.372% | 60.623% |
| iShares S&P 500 | 1.930% | -0.507% | 24.257% | 59.657% |
Comments by tamam for this prediction
In the thread Bristol-Myers Squibb diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 03.01.2019 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 59.93$ zu.
Kursziel geändert auf 62,0
Kursziel geändert auf 72,0
In the thread Trading Bristol-Myers Squibb
Die von tamam gewählte maximale Laufzeit wurde überschritten